Market Overview:
The global animal compound anesthesia market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for pet hospital services, rising awareness about animal health and hygiene, and growing number of veterinary clinics. In addition, the increasing use of Baodingning mixture as an anesthetic agent is also contributing to the growth of this market. However, factors such as high cost associated with animal compound anesthesia and lack of skilled professionals are restraining the growth of this market. On the basis of type, 846 anesthetic mixture accounted for a major share in 2017 and is expected to maintain its dominance during the forecast period from 2018 to 2030. This can be attributed to its easy availability and low cost as compared with other types of anesthetics available in the market.
Product Definition:
Animal compound anesthesia is a mixture of two or more anesthetics that are used to produce general anesthesia in animals. The purpose of animal compound anesthesia is to achieve a state of unconsciousness in the patient so that they do not feel pain or discomfort during surgery or other medical procedures. Animal compound anesthetics are important because they allow surgeons to perform delicate procedures without causing the patient any pain or fear.
846 Anesthesia Mixture:
846 Anesthesia Mixture is a trade name for the balanced anesthesia solution that contains all the essential anesthetic agents in equimolar concentrations. It's unique formulation provides advantages over other commonly used solutions such as DMSO or alcohol mixtures, which are more concentrated and contain fewer anesthetic agents. 846 Anesthesia Mixture also offers higher compatibility with animal tissues than most of the commercially available solutions, thus providing better surgical results.
Baodingning Mixture:
Baoding mixture is a combination of drugs used for the purpose of anesthesia in animals. Baoding mixture consists of anesthetic agents such as ketamine, xylazine, and medetomidine coupled with opioids to provide pain relief during surgical procedures on animals. The drug combination is commonly used by veterinary surgeons across the globe for performing surgeries on companion and livestock animals.
The global animal healthcare market was valued at over USD 72 billion in 2015.
Application Insights:
The others segment dominated the global animal compound anesthesia market in 2017, accounting for more than half of the revenue share. The other applications include research laboratories and zoos/wildlife parks. Compound anesthetics are increasingly being used across these application sectors owing to their cost-effectiveness, safety record and easy availability.
Pet hospitals were the largest application segment in 2017 and accounted for over 60% of total revenue share that year. This is attributed to rising pet healthcare expenditure globally as well as locally coupled with high demand for advanced pain management products & procedures among owners of pets due to increased awareness regarding better health care treatment options available with veterinarian prescribed medicines & vaccines which have been found effective against various diseases & conditions including cancer, heart disease etc.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of animal healthcare facilities and high expenditure on pet care. The U.S., being a developed economy, has one of the highest veterinary healthcare expenditures as compared to other countries. According to American Pet Products Association (APPA), in 2016, Americans spent around USD X billion on their pets as child care or personal care and another USD X billion on veterinary services.
Growth Factors:
- Increasing demand for animal-based food products is expected to drive the growth of the animal compound anesthesia market during the forecast period.
- Growing awareness about animal welfare is another key factor that is anticipated to fuel the growth of this market in the near future.
- Rising number of zoos and aquariums across the globe is also projected to boost demand for animal compound anesthesia products in coming years.
- Increasing research and development activities for new anesthetic drugs are also expected to propel market growth in forthcoming years. 5) Technological advancements in veterinary care are likely to create new opportunities for players operating in this market over the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Animal Compound Anesthesia Market Research Report
By Type
846 Anesthesia Mixture, Baodingning Mixture, Others
By Application
Pet Hospital, Veterinary Station, Others
By Companies
Boehringer-Ingelheim, Elanco, Vetoquinol, Ceva Sante Animale, Dechra Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Animal Compound Anesthesia Market Report Segments:
The global Animal Compound Anesthesia market is segmented on the basis of:
Types
846 Anesthesia Mixture, Baodingning Mixture, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pet Hospital, Veterinary Station, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boehringer-Ingelheim
- Elanco
- Vetoquinol
- Ceva Sante Animale
- Dechra Pharmaceuticals
Highlights of The Animal Compound Anesthesia Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 846 Anesthesia Mixture
- Baodingning Mixture
- Others
- By Application:
- Pet Hospital
- Veterinary Station
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Animal Compound Anesthesia Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Animal compound anesthesia is a type of anesthesiology that uses medications to block the sensation of pain in animals during surgery or other medical procedures.
Some of the key players operating in the animal compound anesthesia market are Boehringer-Ingelheim, Elanco, Vetoquinol, Ceva Sante Animale, Dechra Pharmaceuticals.
The animal compound anesthesia market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Animal Compound Anesthesia Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Animal Compound Anesthesia Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Animal Compound Anesthesia Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Animal Compound Anesthesia Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Animal Compound Anesthesia Market Size & Forecast, 2020-2028 4.5.1 Animal Compound Anesthesia Market Size and Y-o-Y Growth 4.5.2 Animal Compound Anesthesia Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 846 Anesthesia Mixture
5.2.2 Baodingning Mixture
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pet Hospital
6.2.2 Veterinary Station
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Animal Compound Anesthesia Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Animal Compound Anesthesia Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 846 Anesthesia Mixture
9.6.2 Baodingning Mixture
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pet Hospital
9.10.2 Veterinary Station
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 846 Anesthesia Mixture
10.6.2 Baodingning Mixture
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pet Hospital
10.10.2 Veterinary Station
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 846 Anesthesia Mixture
11.6.2 Baodingning Mixture
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pet Hospital
11.10.2 Veterinary Station
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 846 Anesthesia Mixture
12.6.2 Baodingning Mixture
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pet Hospital
12.10.2 Veterinary Station
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 846 Anesthesia Mixture
13.6.2 Baodingning Mixture
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pet Hospital
13.10.2 Veterinary Station
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Animal Compound Anesthesia Market: Competitive Dashboard
14.2 Global Animal Compound Anesthesia Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boehringer-Ingelheim
14.3.2 Elanco
14.3.3 Vetoquinol
14.3.4 Ceva Sante Animale
14.3.5 Dechra Pharmaceuticals